What is Alfresa Holdings Corporation (ARHCF)?

Alfresa Holdings Corporation (ARHCF) is a stock in the Healthcare sector, Medical - Distribution industry. View full analysis on Stocks360.

What is the current price of ARHCF?

The current price of ARHCF is $14.00. Prices are updated in real time on Stocks360.

What is ARHCF's price-to-earnings (PE) ratio?

ARHCF's trailing twelve-month PE ratio is 11.24, based on current price and earnings per share data available on Stocks360.

What is ARHCF's market capitalization?

ARHCF's market capitalization is $2,455,788,608.00, placing it in the mid-cap tier.

Does ARHCF pay a dividend?

Yes. ARHCF has a trailing twelve-month dividend yield of 0.03%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Alfresa Holdings Corporation (ARHCF)

Stock analysis · OTC · Healthcare · Medical - Distribution

$14.00

Market Cap

$2.46B

PE (TTM)

11.24

EPS (TTM)

N/A

Dividend Yield

2.84%

Beta

0.08

Day Range

$14.00 – $14.00

52-wk Range

$11.87 – $14.59

Avg Volume

N/A

Volume

2.70K

Alfresa Holdings Corporation (ARHCF) is a publicly traded company in the Healthcare sector. Latest price: $14.00. Market cap $2.46B. Trailing PE 11.24. Dividend yield 2.84%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-28 · $11.87 2026-10-26 · $14.00 (+17.94%)

Earnings

Most Recent

Aug 5, 2026

EPS $0.09 vs est. $0.21

Missed by $0.12

Next Earnings

Nov 9, 2026

EPS estimate $0.19

Proprietary Signals

Signal snapshot temporarily unavailable.

About Alfresa Holdings Corporation

Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	11.24×
P/S (TTM)	0.14×
P/B	0.89×
PEG	0.26×
P/FCF (TTM)	0.00×
EV / EBITDA	3.48×
EV / Sales	0.08×
Earnings Yield	9.03%
Free Cash Flow Yield	0.00%
Dividend Yield	2.84%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$263.84B
Revenue (TTM)	$3.13T
Net Income (TTM)	$38.47B
Free Cash Flow (TTM)	$243.85M
Net Debt	-$162.07B
Working Capital	$201.73B
Gross Margin	6.98%
Operating Margin	1.11%
Net Margin	1.25%
Return on Equity	7.93%
Return on Invested Capital	4.23%